BIOCRYST PHARMACEUTICALS INC Quarterly Unrecognized Tax Benefits in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Biocryst Pharmaceuticals Inc quarterly Unrecognized Tax Benefits history and growth rate from Q4 2012 to Q4 2023.
  • Biocryst Pharmaceuticals Inc Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $14.4M, a 3.74% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $14.4M +$518K +3.74% Dec 31, 2023 10-K 2024-02-27
Q4 2022 $13.8M +$4.12M +42.3% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $9.73M +$1.5M +18.2% Dec 31, 2021 10-K 2024-02-27
Q4 2020 $8.23M +$1.02M +14.1% Dec 31, 2020 10-K 2023-02-27
Q4 2019 $7.21M +$1.23M +20.6% Dec 31, 2019 10-K 2022-02-28
Q4 2018 $5.98M +$1.23M +25.8% Dec 31, 2018 10-K 2021-03-01
Q4 2017 $4.75M +$495K +11.6% Dec 31, 2017 10-K 2020-03-13
Q4 2016 $4.26M +$1.17M +37.9% Dec 31, 2016 10-K 2019-03-14
Q4 2015 $3.09M +$2.61M +554% Dec 31, 2015 10-K 2018-03-12
Q4 2014 $472K +$188K +66.2% Dec 31, 2014 10-K 2017-02-27
Q4 2013 $284K +$284K Dec 31, 2013 10-K 2016-02-26
Q4 2012 $0 Dec 31, 2012 10-K 2013-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.